Cite
Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil.
MLA
de Sá, Nathalia Beatriz Ramos, et al. “Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil.” BioMed Research International, vol. 2022, Sept. 2022, p. 9082455. EBSCOhost, https://doi.org/10.1155/2022/9082455.
APA
de Sá, N. B. R., Neira-Goulart, M., Ribeiro-Alves, M., Perazzo, H., Geraldo, K. M., Ribeiro, M. P. D., Cardoso, S. W., Grinsztejn, B., Veloso, V. G., Capão, A., Siqueira, M. M., de Lima Bezerra, O. C., Garcia, C. C., Gomes, L. R., da Silva Cazote, A., de Almeida, D. V., Giacoia-Gripp, C. B. W., Côrtes, F. H., & Morgado, M. G. (2022). Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil. BioMed Research International, 2022, 9082455. https://doi.org/10.1155/2022/9082455
Chicago
de Sá, Nathalia Beatriz Ramos, Milena Neira-Goulart, Marcelo Ribeiro-Alves, Hugo Perazzo, Kim Mattos Geraldo, Maria Pia Diniz Ribeiro, Sandra Wagner Cardoso, et al. 2022. “Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil.” BioMed Research International 2022 (September): 9082455. doi:10.1155/2022/9082455.